eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

5/2021
vol. 13
 
Share:
Share:
more
 
 
abstract:
Letter to the Editor

Acute parotitis in high-dose-rate brachytherapy treatment for skin cancer: a case report

Silvia Rodríguez Villalba
1
,
María José Pérez-Calatayud
2
,
Jose Pérez-Calatayud
1, 3
,
Jose Richart Sancho
1, 4
,
Manuel Santos Ortega
1

1.
Radiotherapy Department, Hospital Clínica Benidorm, Alicante, Spain
2.
Radiotherapy Department, Hospital General de Valencia, ERESA, Valencia, Spain
3.
Radiotherapy Department, La Fe University and Polytechnic Hospital, Valencia, Spain
4.
Radiotherapy Department, Hospital Iniversitario San Juan, San Juan de Alicante, Alicante, Spain
J Contemp Brachytherapy 2021; 13, 5: 493–496
Online publish date: 2021/10/14
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Brachytherapy (BT) for skin cancer is an accepted alternative technique, where surgical scars may be of cosmetic concern, or for elderly patients due to significant comorbidity. BT is used for macroscopic disease and as an adjuvant to surgery (after local excision due to positive or close margins or other unfavorable prognostic factors) [1-3].

The objective of this case report was to examine clinical evolution of a patient who unexpectedly developed an acute parotitis, after second adjuvant superficial brachytherapy fraction in the preauricular area. This unusual toxicity has been described in patients receiving external radiotherapy (EBRT) whose parotid gland was included within irradiation volume. After ruling out other causes of unilateral parotitis, clinical evolution, and dosimetric analysis, this reaction was attributed to BT treatment, showing the same known clinical situation but rarely appearing with low-dose external beam treatments. To our knowledge, this unusual toxicity has not been published previously, when BT was employed.
 
Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.